{"entity":{"id":"alinta-hegmane","kind":"person","name":"Alinta Hegmane","aka":[],"tldr":"Alinta Hegmane represents Riga East University Hospital / Oncology Centre of Latvia in the Organisation of European Cancer Institutes, which lists the centre among its members in Latvia.","summary":"Alinta Hegmane is listed by the Organisation of European Cancer Institutes (OECI) as the representative of Riga East University Hospital / Oncology Centre of Latvia, its full member in Latvia. OnCo records the name from the OECI membership list so that the centre's page names its contact within Europe's cancer-centre network; the person's clinical or management role is not stated by the list and should be checked at the institution's website.","asOf":"2026-09-10","links":[{"label":"OECI membership list","url":"https://www.oeci.eu/Membership.aspx"},{"label":"Riga East University Hospital / Oncology Centre of Latvia website","url":"https://www.aslimnica.lv"}],"tags":["oeci-representative","leader"],"related":["oeci"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["riga-east-university-hospital"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Representative of Riga East University Hospital / Oncology Centre of Latvia to the Organisation of European Cancer Institutes","institutionId":"riga-east-university-hospital","specialisms":["Cancer centre representation (OECI)"],"profiles":[{"label":"OECI membership list","url":"https://www.oeci.eu/Membership.aspx"},{"label":"Riga East University Hospital / Oncology Centre of Latvia website","url":"https://www.aslimnica.lv"}],"papers":[{"title":"European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer","journal":"Annals of Oncology","year":2021,"url":"https://doi.org/10.1016/j.annonc.2021.11.013","doi":"10.1016/j.annonc.2021.11.013","note":"OpenAlex author record matched by institution"},{"title":"Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells","journal":"Cancer Chemotherapy and Pharmacology","year":2014,"url":"https://doi.org/10.1007/s00280-014-2635-1","doi":"10.1007/s00280-014-2635-1","note":"OpenAlex author record matched by institution"},{"title":"Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer","journal":"Cancers","year":2022,"url":"https://doi.org/10.3390/cancers14071598","doi":"10.3390/cancers14071598","note":"OpenAlex author record matched by institution"}]},"route":"/people/alinta-hegmane/","neighbours":{"institution":[{"id":"oeci","kind":"institution","name":"Organisation of European Cancer Institutes","route":"/institutions/oeci/"},{"id":"riga-east-university-hospital","kind":"institution","name":"Riga East University Hospital / Oncology Centre of Latvia","route":"/institutions/riga-east-university-hospital/"}]}}